Legal & General Group
GNCA

Legal & General Group’s Genocea Biosciences, Inc. GNCA Stock Holding History

Legal & General Group’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,802
Closed -$15K – 3432
2018
Q1 		$15K Buy
1,802
+1,274
+241% +$10.6K ﹤0.01% 3168
2017
Q4 		$5K Hold
528
– – ﹤0.01% 3265
2017
Q3 		$6K Hold
528
– – ﹤0.01% 3294
2017
Q2 		$22K Buy
+528
New +$25.4K ﹤0.01% 3159

Other funds holding GNCA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Legal & General Group's GNCA Position: Q2 2018 in Review

Legal & General Group sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2018, closing a stake of 1,802 shares — an estimated $15K sold.

Legal & General Group first reported a position in GNCA in Q2 2017 and held it in 4 quarters. The position peaked at $22K in Q2 2017. 54 funds tracked by Wall St. Rank hold GNCA as of Q2 2018.

  • Legal & General Group reported no remaining Genocea Biosciences, Inc. position as of Q2 2018 after selling out during the quarter.
  • Legal & General Group sold 1,802 Genocea Biosciences, Inc. shares in Q2 2018, an estimated $15K.
  • Legal & General Group first reported a position in Genocea Biosciences, Inc. in Q2 2017 and held it in 4 quarters.
  • Legal & General Group's Genocea Biosciences, Inc. position peaked at $22K in Q2 2017.
  • 54 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2018.

Based on Legal & General Group's 13F filing for Q2 2018, filed 10 Aug 2018.